Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (201-210 of 282) with videos related to

Pageof 29
Sort By:
Pharmacogenomics|June 11, 2013
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillationTalitha I Verhoef, William K Redekop, David L Veenstra, et al.
Pediatric Diabetes|November 8, 2014
Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the NetherlandsSoulmaz Fazeli Farsani, Patrick C Souverein, Marja M J van der Vorst, et al.
British Journal of Clinical Pharmacology|February 18, 2014
Beliefs about medicines in Dutch acenocoumarol and phenprocoumon usersTalitha I Verhoef, W Ken Redekop, Marcel L Bouvy, et al.
International Journal of Cancer|January 26, 2016
Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Ursula Amstutz, et al.
Atherosclerosis|June 8, 2002
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitorsAnke Hilse Maitland-van der Zee, Olaf H Klungel, Bruno H Ch Stricker, et al.
Clinical Pharmacology and Therapeutics|March 5, 2021
COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European UnionAmos Jochanan de Jong, Yared Santa-Ana-Tellez, Ghislaine José Madeleine Wilhelmien van Thiel, et al.
BMC Cancer|March 1, 2018
The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumorsHeleen K Bronsveld, Marie L De Bruin, Jelle Wesseling, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fractureMd Jamal Uddin, Rolf H H Groenwold, Anthonius de Boer, et al.
Frontiers in Medicine|December 27, 2021
Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple StakeholdersJorn Mulder, Robin Verjans, Ciska Verbaanderd, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2011
[Interaction between clopidogrel and proton pump inhibitors]Ankie M Harmsze, Anthonius de Boer, Henk Boot, et al.
Pageof 29

Showing results (201-210 of 282) with videos related to

Sort By:
Pageof 29
Pharmacogenomics|June 11, 2013
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillationTalitha I Verhoef, William K Redekop, David L Veenstra, et al.
Pediatric Diabetes|November 8, 2014
Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the NetherlandsSoulmaz Fazeli Farsani, Patrick C Souverein, Marja M J van der Vorst, et al.
British Journal of Clinical Pharmacology|February 18, 2014
Beliefs about medicines in Dutch acenocoumarol and phenprocoumon usersTalitha I Verhoef, W Ken Redekop, Marcel L Bouvy, et al.
International Journal of Cancer|January 26, 2016
Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Ursula Amstutz, et al.
Atherosclerosis|June 8, 2002
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitorsAnke Hilse Maitland-van der Zee, Olaf H Klungel, Bruno H Ch Stricker, et al.
Clinical Pharmacology and Therapeutics|March 5, 2021
COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European UnionAmos Jochanan de Jong, Yared Santa-Ana-Tellez, Ghislaine José Madeleine Wilhelmien van Thiel, et al.
BMC Cancer|March 1, 2018
The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumorsHeleen K Bronsveld, Marie L De Bruin, Jelle Wesseling, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fractureMd Jamal Uddin, Rolf H H Groenwold, Anthonius de Boer, et al.
Frontiers in Medicine|December 27, 2021
Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple StakeholdersJorn Mulder, Robin Verjans, Ciska Verbaanderd, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2011
[Interaction between clopidogrel and proton pump inhibitors]Ankie M Harmsze, Anthonius de Boer, Henk Boot, et al.
Pageof 29